
Fagron company profile
Activities of Fagron
Situation on 29 January 2021, based on the notifications received:
Number of shares | % of effective voting rights | |
---|---|---|
Alychlo NV / Marc Coucke | 10,749,267 | 14.96% |
The Capital Group Companies | 7,553,899 | 10.47% |
NN Group NV | 7,178,279 | 9.95% |
Kabouter Management LLC | 2,286,973 | 3.17% |
BNP Paribas Asset Management SA | 2,172,099 | 3.00% |
Article 11 of the articles of association of the company specifies that participations must be notified as soon as a threshold of 3%, 5% and any multiple of 5% has been passed.
The number of Fagron shares with voting rights is 72,477,654. The total number of voting rights (denominator) is 72,477,654.
Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 35 countries worldwide.